Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coherus Oncology (CHRS) Debt Ratio (2016 - 2025)

Coherus Oncology's Debt Ratio history spans 12 years, with the latest figure at 0.14 for Q4 2025.

  • For Q4 2025, Debt Ratio rose 27.84% year-over-year to 0.14; the TTM value through Dec 2025 reached 0.14, up 27.84%, while the annual FY2025 figure was 0.14, 27.84% up from the prior year.
  • Debt Ratio for Q4 2025 was 0.14 at Coherus Oncology, up from 0.07 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.61 in Q1 2023 and bottomed at 0.07 in Q2 2024.
  • The 5-year median for Debt Ratio is 0.13 (2024), against an average of 0.24.
  • The largest annual shift saw Debt Ratio surged 359.28% in 2022 before it plummeted 87.06% in 2024.
  • A 5-year view of Debt Ratio shows it stood at 0.11 in 2021, then soared by 359.28% to 0.51 in 2022, then fell by 22.29% to 0.4 in 2023, then crashed by 71.72% to 0.11 in 2024, then rose by 27.84% to 0.14 in 2025.
  • Per Business Quant, the three most recent readings for CHRS's Debt Ratio are 0.14 (Q4 2025), 0.07 (Q3 2025), and 0.08 (Q2 2025).